Fragment-Based Drug Discovery
Raymond S. Norton Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic. 3052, Australia.
Email: ray.norton@monash.edu
Ray Norton holds a personal chair at the Monash Institute of Pharmaceutical Sciences, Parkville, where his research focuses on therapeutically useful toxins, malaria surface proteins as vaccine candidates and drug targets, and fragment-based drug discovery against a range of targets. He has a B.Sc. (Hons) degree from the University of Melbourne and a Ph.D. from the Australian National University. Following post-doctoral study in the US, he was awarded a QEII Fellowship to work at the Roche Research Institute of Marine Pharmacology in Sydney, and was subsequently appointed as a staff research scientist. In 1981, he moved to a faculty position in the School of Biochemistry at the University of New South Wales, and in 1992 he took up the positions of Head of the NMR Laboratory at the Biomolecular Research Institute in Melbourne and Assistant Director. In 2001, his group became part of the new Structural Biology Division of the Walter and Eliza Hall Institute of Medical Research, before moving to Monash in 2010. His achievements have been recognised by several awards: the Amersham Pharmacia Biotech Medal of the Australian Society of Biochemistry & Molecular Biology in 1998, the ANZMAG Medal of the Australian and New Zealand Society for Magnetic Resonance in February 2006, and the Sir Rutherford Robertson Medal of the Australian Society for Biophysics (ASB) in 2008. He has published nearly 300 articles and holds several patents. |
Australian Journal of Chemistry 66(12) 1463-1464 https://doi.org/10.1071/CH13492
Published: 6 December 2013
References
[1] C. W. Murray, M. L. Verdonk, D. C. Rees, Trends Pharmacol. Sci. 2012, 33, 224.| Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XkslejsLs%3D&md5=607aedb024364d01b085fe259a2f2409CAS | 22459076PubMed |
[2] B. C. Doak, C. J. Morton, J. S. Simpson, M. J. Scanlon, Aust. J. Chem. 2013, 66, 1465.
| Crossref | GoogleScholarGoogle Scholar |
[3] C. L. Francis, P. W. Kenny, O. Dolezal, S. Saubern, M. Kruger, G. P. Savage, T. S. Peat, J. H. Ryan, Aust. J. Chem. 2013, 66, 1473.
| Crossref | GoogleScholarGoogle Scholar |
[4] J. B. Baell, L. Ferrins, H. Falk, G. Nikolakopoulos, Aust. J. Chem. 2013, 66, 1483.
| Crossref | GoogleScholarGoogle Scholar |
[5] S.-A. Poulsen, Aust. J. Chem. 2013, 66, 1495.
| Crossref | GoogleScholarGoogle Scholar |
[6] R. M. McMahon, M. J. Scanlon, J. L. Martin, Aust. J. Chem. 2013, 66, 1502.
| Crossref | GoogleScholarGoogle Scholar |
[7] O. Dolezal, L. Doughty, M. K. Hattarki, V. J. Fazio, T. T. Caradoc-Davies, J. Newman, T. S. Peat, Aust. J. Chem. 2013, 66, 1507.
| Crossref | GoogleScholarGoogle Scholar |
[8] A. Vom, S. J. Headey, G. Wang, B. Capuano, E. Yuriev, M. J. Scanlon, J. S. Simpson, Aust. J. Chem. 2013, 66, 1518.
| Crossref | GoogleScholarGoogle Scholar |
[9] S. J. Headey, M. C. Pearce, M. J. Scanlon, S. P. Bottomley, Aust. J. Chem. 2013, 66, 1525.
| Crossref | GoogleScholarGoogle Scholar |
[10] S. S. Lim, C. O. Debono, C. A. MacRaild, I. R. Chandrashekaran, O. Dolezal, R. F. Anders, J. S. Simpson, M. J. Scanlon, S. M. Devine, P. J. Scammells, R. S. Norton, Aust. J. Chem. 2013, 66, 1530.
| Crossref | GoogleScholarGoogle Scholar |
[11] S. Chhabra, O. Dolezal, M. K. Hattarki, T. S. Peat, J. S. Simpson, J. D. Swarbrick, Aust. J. Chem. 2013, 66, 1537.
| Crossref | GoogleScholarGoogle Scholar |
[12] M. J. Drysdale, Aust. J. Chem. 2013, 66, 1544.
| Crossref | GoogleScholarGoogle Scholar |
[13] A. D. Morley, A. Pugliese, K. Birchall, J. Bower, P. Brennan, N. Brown, T. Chapman, M. Drysdale, I. H. Gilbert, S. Hoelder, A. Jordan, S. V. Ley, A. Merritt, D. Miller, M. E. Swarbrick, P. G. Wyatt, Drug Discov. Today 2013,
| Crossref | GoogleScholarGoogle Scholar | 23906694PubMed |
